ASX ANNOUNCEMENT 21 October 2026 Voluntary Field Action for Certain Evoke® System Devices Saluda Medical, Inc. (ASX:SLD, “Saluda” or the “Company”) today advised that it is initiating a voluntary field action involving a defined population of Evoke® Closed Loop Stimulators following...
Voluntary Field Action for Certain Evoke System Devices
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Saluda Medical Inc is initiating a voluntary field action for certain Evoke Closed Loop Stimulators due to a low-incidence issue related to a third-party manufacturing process change. The company reported a very low complaint rate among implanted devices, with a small number of complaints identified over a significant period. Saluda is advising physicians to continue routine patient management and is not recommending prophylactic replacements for the affected devices. The company does not expect this action to disrupt product supply or materially affect its operations.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Saluda Medical
- Notification of cessation of securities - SLD
- Notification regarding unquoted securities - SLD
- Expands Access with Full US Commercial Release of CAP24
- Initial Director's Interest Notice
- Director Appointment/Resignation
Later from Saluda Medical
- Notice of Annual Stockholders Meeting and CDI Voting Form
- Annual Report to Stockholders
- Appendix 4G and Corporate Governance Statement
- Vesting of RSUs
- Quarterly Appendix 4C Cash Flow Report
Follow Saluda Medical into a list and get an email when it puts out news.
Follow Saluda Medical